These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1519426)

  • 1. Growth hormone secretion in patients with Turner's syndrome as determined by time series analysis.
    Wit JM; Massarano AA; Kamp GA; Hindmarsh PC; van Es A; Brook CG; Preece MA; Matthews DR
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):7-12. PubMed ID: 1519426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsatile growth hormone release in Turner's syndrome and short normal children.
    Ghizzoni L; Lamborghini A; Ziveri M; Volta C; Panza C; Balestrazzi P; Bernasconi S
    Acta Endocrinol (Copenh); 1990 Sep; 123(3):291-7. PubMed ID: 2239077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased metabolic clearance of endogenous growth hormone and specific alterations in the pulsatile mode of growth hormone secretion occur in prepubertal girls with Turner's syndrome. Genentech Collaborative Group.
    Veldhuis JD; Sotos JF; Sherman BM
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1073-80. PubMed ID: 1939522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Mouton JW; Blum WF; Mercado M; Baumann G; Drop SL
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):77-84. PubMed ID: 7688672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
    Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating growth hormone isoforms in girls with Turner's syndrome.
    Blethen SL; Albertsson-Wikland K; Faklis EJ; Chasalow FI
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1439-43. PubMed ID: 8200948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol.
    Massarano AA; Brook CG; Hindmarsh PC; Pringle PJ; Teale JD; Stanhope R; Preece MA
    Arch Dis Child; 1989 Apr; 64(4):587-92. PubMed ID: 2751332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
    Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
    Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-four hour plasma GH, FSH and LH profiles in patients with Turner's syndrome.
    Villadolid MC; Takano K; Hizuka N; Asakawa K; Sukegawa I; Horikawa R; Shizume K
    Endocrinol Jpn; 1988 Feb; 35(1):71-81. PubMed ID: 3135180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome.
    Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M
    Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow baseline growth and a good response to growth hormone (GH) therapy are related to elevated spontaneous GH pulse frequency in girls with Turner's syndrome.
    Kamp GA; Kuilboer MM; Wynne HJ; Rongen-Westerlaken C; Johnson ML; Veldhuis JD; Wit JM
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1604-9. PubMed ID: 8501169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
    Haeusler G; Frisch H
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
    Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.
    Reiter JC; Craen M; Van Vliet G
    Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone secretion in pubertal age patients with Turner's syndrome.
    Lanes R; Brito S; Suniaga M; Moncada G; Borges M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):770-2. PubMed ID: 2394779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
    Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol.
    Martínez A; Heinrich JJ; Domené H; Escobar ME; Jasper H; Montuori E; Bergadá G
    J Clin Endocrinol Metab; 1987 Aug; 65(2):253-7. PubMed ID: 3597706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.